Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 3/20 | 0.44 |
| ▸ | NOS3 | P29474 | 2/20 | 0.41 |
| ▸ | NOS2 | P35228 | 1/20 | 0.41 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HTR1A | P08908 | 3/20 | 0.34 |
| ▸ | HTR7 | P34969 | 3/20 | 0.34 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.34 |
| ▸ | NISCH | Q9Y2I1 | 3/20 | 0.34 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6985896 | 0.83 | MAOA (0.44) | MAOANOS3NOS2MAPK10KDM4E | |
| SCHEMBL6983307 | 0.83 | NOS3 (0.45) | MAOANOS3NOS2MAPK10KDM4E | |
| SCHEMBL6987417 | 0.80 | MAPT (0.54) | MAOANOS3NOS2MAPK10ALDH1A1 | |
| SCHEMBL6991272 | 0.80 | MAOA (0.42) | MAOANOS3NOS2MAPK10KDM4E | |
| SCHEMBL4114094 | 0.79 | NOS3 (0.49) | MAOANOS3NOS2MAPK10KDM4E | |
| SCHEMBL6986286 | 0.78 | MAOA (0.40) | MAOANOS3NOS2MAPK10KDM4E | |
| SCHEMBL4113361 | 0.75 | MAOA (0.41) | MAOANOS3NOS2MAPK10KDM4E | |
| SCHEMBL6986045 | 0.75 | NISCH (0.40) | MAOANOS3NOS2MAPK10ALDH1A1 | |
| SCHEMBL6986330 | 0.73 | NOS3 (0.41) | MAOANOS3NOS2MAPK10KDM4E | |
| SCHEMBL6986047 | 0.73 | MAOA (0.43) | MAOANOS3NOS2MAPK10KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8129554-B2 | Metal complexes | MERCK PATENT GMBH (DE) | 2012-03-06 | — | — | US | disclosed |
| US-8129554-B2 | Metal complexes | MERCK PATENT GMBH (DE) | 2012-03-06 | — | — | US | disclosed |
| EP-1915386-B1 | METAL COMPLEX | MERCK PATENT GMBH (DE) | 2011-06-08 | — | — | EP | disclosed |
| US-20090118453-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2009-05-07 | — | — | US | disclosed |
| US-20090118453-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2009-05-07 | — | — | US | disclosed |
| WO-2007019942-A1 | METAL COMPLEX | MERCK PATENT GMBH (DE) | 2007-02-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090118453-A1 | METAL COMPLEXES | SOD1, AP1M1, AP2M1 | MAOA 686/4885NOS3 2910/4885NOS2 2387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.